Solventum Corporation SOLV
89.50
0.91
1.03%
as of 25 Sep
- Market cap
- $15.1B
- P/E
- 10.9×
Follow SOLV
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Solventum Corporation (SOLV) Gross margin
Solventum Corporation's gross margin over the twelve months to 30 June 2026 was 54.7%, up 1.2 percentage points from fiscal 2025 (53.5%). That is in line with the Medical Instruments & Supplies industry median of 54.6% and in line with the Healthcare sector median of 53.7%.
Gross margin, annual
Annual
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 53.5% | (2.18) |
| FY2024 | 55.7% | (1.60) |
| FY2023 | 57.3% | (0.50) |
| FY2022 | 57.8% | — |
Quarterly
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 58.2% | 3.61 |
| Mar 2026 | 54.6% | 3.21 |
| Dec 2025 | 51.4% | (2.75) |
| Sep 2025 | 54.2% | (0.22) |
| 10 more quarters | Free account |
Gross margin against peers
| Company | Gross margin |
|---|---|
| ALGN Align Technology, Inc. compare | 68.1% |
| COO The Cooper Companies, Inc. compare | 65.9% |
| ALC Alcon compare | 56.9% |
| SOLV Solventum Corporation | 54.7% |
| RGEN Repligen Corporation compare | 53.5% |
| WST West Pharmaceutical Services, Inc. compare | 36.8% |
| ATR AptarGroup, Inc. compare | 36.1% |
| AVTR Avantor, Inc. compare | 31.8% |
| BAX Baxter International Inc. compare | 30.1% |
| Medical Instruments & Supplies industry median | 54.6% |
| Healthcare sector median | 53.7% |
| Market median | 46.3% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on SOLV
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement